The SCOPE China Clinical Development Partnering Forum

Tuesday: February 18, 2020 from 2:00 to 5:00 pm at CHI’s SCOPE Summit in Orlando

The new China Clinical Development Partnering Forum at SCOPE provides a focused to connect Chinese clinical development leaders and experts with their counterparts from the US as well as rest of world. The forum will provide a great opportunity for Global and Chinese-based pharmaceutical companies, biotech companies, academic research centers, CROs, consultancies and other service providers involved in the conduct of drug development and clinical trials to share best practices for developing and bringing new therapies to market here in the West and in China. The forum will provide an environment that allows public and/or private dialogue among clinical development counterparts around world.  It will help US or European sponsors and CROs who are interested in conducting clinical development programs in China to partner with up-and-coming Chinese biotech companies and CROs. Vice versa, it will help Chinese innovators and CROs who are looking for US-based CROs or licensing partners to expand their market and reach to collaborate. The forum is not only about “outsourcing,” but focuses more on research-based innovators on both sides trying to figure out a win-win and trying to help one another navigate a two-way partnership. The forum will feature case studies, round table discussions, “how to” panel discussions, and networking. The atmosphere will be casual and interactive, though the topic is very important and somewhat complicated at this moment in time. Speaking proposals and panel proposals are being accepted, but they must include actual best practices and leaders who can offer accurate advice on how best to find partners on both sides. Key information:

  • Attending: There is no added cost to attend this event at SCOPE, but Attendees and Speakers must be registered as a “Best Value” SCOPE conference participant (using discount code CHINA). If you would like to attend, please save your seat by registering with Melissa Dolen at mdolen@healthtech.com or (+1) 781-972-5418 or online at https://register.healthtech.com/reg?SCO20&ID=19798&CO=0
  • Speaking or Hosting a Panel: We are accepting abstract submissions from Chinese biopharma sponsors and service providers & US/European biopharma sponsors and service providers. Please avoid general overviews. Please offer very specific guidance, data and case studies. Proposals from senior thought leaders and panels featuring key stakeholders are requested. The deadline for submissions is October 30, 2019. Please use the online submission form The SCOPE China Clinical Development Partnering Forum:
  • Exhibiting or Underwriting: Please contact Ilana Quigley or Patricia Rose: https://www.scopesummit.com/sponsorship-opportunities

SUBMIT YOUR SCOPE China Clinical Development Partnering Forum PROPOSAL!!!

Key Contacts

For content and speaker suggestions:

Micah Lieberman
Executive Director, Conferences
Cambridge Healthtech Institute (CHI)
T: (+1) 541-482-4709
E: mlieberman@healthtech.com

For Partnering and sponsorship information, (Companies A-O) contact:

Ilana Quigley
Senior Manager, Business Development
Cambridge Healthtech Institute (CHI)
T: (+1) 781-972-5457
E: iquigley@healthtech.com

For Partnering and sponsorship information, (Companies P-Z) contact:

Patty Rose
Sr. Business Development Manager
Cambridge Healthtech Institute (CHI)
T: 781.972.1349
E: prose@healthtech.com

Group Discounts Are Available!
Special rates are available for multiple attendees from the same organization.

For more information on group discounts, contact:

Melissa Dolen
T: (+1) 781-972-5418
E: mdolen@healthtech.com

About SCOPE:
Celebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. SCOPE attracted more than 2,200 leaders in clinical operations and research in 2019 and we are expecting record attendance in 2020. Over the course of four stimulating days of in-depth discussions in 20 different conferences, 3 plenary keynote sessions, the annual Participant Engagement Awards, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations, including: Site Selection and Management, Patient Engagement, Recruitment and Retention, Protocol Optimization, Feasibility, Data Strategy and Analytics, Sensors and Wearables, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Resource Management, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Artificial Intelligence, Post-Marketing Studies, Observational Research, Accessing and Generating RWD, Clinical Biomarker Strategy, Clinical Supply Chain, Precision Medicine, Clinical Biomarkers and Biospecimens, and Central Lab Solutions, and an all new track on Medical Device Clinical Trial Operations and Regulations. SCOPE is brought to you by Cambridge Innovation Institute (CII) and Cambridge Healthtech Institute (CHI), the organizers of Bio-IT World, AI World, Next Generation Diagnostics, PEGS, PepTalk, Discovery on Target and other events.


SCOPE 2019 attracts record attendance with more than 2,000 participants

A Leader in the Clinical Trial Industry: SCOPE Grows by 20% for the fourth consecutive year

2019 Event Features
  • 2,000+ participants
  • 19 conferences
  • Participant Engagement Awards
  • Dedicated Exhibit Hall Hours & Networking Functions
  • Interactive Breakout Discussions
  • Greater Gift Vaccine Dontations

SUBMIT YOUR SCOPE China Clinical Development Partnering Forum PROPOSAL!!!


The impressive executive audience at SCOPE came together for invaluable networking opportunities with more than 52% of the attendees titled as a decision maker from leading Pharma (20%), CRO (35%), and Biotech companies (20%). Industry leaders and key decision makers representing 28 different countries and more than 700 unique organizations shared case studies, collaborated on best practices and provided unique perspectives on poignant issues that the field currently faces.


2019 Attendee Demographics